379 filings
Page 9 of 19
8-K
2bztp1cv5d
29 Oct 13
Arca Biopharma Announces Ind Submission to Us Fda for Gencaro
12:00am
8-K
dj8r2kv4ti7
23 Sep 13
Departure of Directors or Certain Officers
12:00am
8-K
ox5yb8fq
4 Sep 13
Robert E. Conway Appointed to Arca Biopharma Board of Directors
12:00am
8-K
vnsb kk0yldp
6 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K
c2b9pnc
30 Jul 13
Raymond L. Woosley, M.D., PH.D. Appointed to Arca Biopharma Board of Directors
12:00am
8-K
h0o38tkbk8se6
25 Jul 13
ARCA biopharma Announces Additions to GENETIC-AF Leadership Team
12:00am
8-K
pjmvrtn tl3mkr0
18 Jul 13
Arca Biopharma Provides Business Update
12:00am
8-K
v44pnv
1 Jul 13
Regulation FD Disclosure
12:00am
8-K
w0hmkp6 23o
18 Jun 13
Departure of Directors or Certain Officers
12:00am
8-K
y7lc6
6 Jun 13
Pharmacogenetic Enhancement of Effectiveness for Prevention of Atrial
12:00am
8-K
pneu0fr
30 May 13
Arca Biopharma Announces Pricing of $20 Million Equity Offering
12:00am
8-K/A
ii5uapbtezx5 01k
9 May 13
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
ck7t 0cxakgzyqq5b
6 May 13
Departure of Directors or Certain Officers
12:00am
8-K
awx62mq7
23 Apr 13
This presentation contains "forward-looking statements" for purposes of the safe harbor provided by the Private Securities Litigation Reform
12:00am
8-K
tu2 83xe931n9k
22 Apr 13
Entry into a Material Definitive Agreement
12:00am
8-K
h2132pl9e1b6h3
25 Mar 13
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
97ucw7t5 d8j8
5 Mar 13
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
syp 8hrrsk1
28 Feb 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
etsb ac246st
6 Feb 13
Other Events
12:00am
8-K
s2vzf7xh6m8 4asa73vb
1 Feb 13
Entry into a Material Definitive Agreement
12:00am